Offer - Urjas Oil for just ₹ 1
Moxitas 125 Syrup is a prescription medicine that is available as a Syrup. Primarily, it is used for the treatment of Bacterial Infections, Throat Infection, Upper Respiratory Tract Infection. Moxitas 125 Syrup also has some secondary and off-label uses. These are listed below.
The optimal dosage of Moxitas 125 Syrup is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Some other side effects of Moxitas 125 Syrup have been listed ahead. Such side effects of Moxitas 125 Syrup normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Moxitas 125 Syrup's effect is Mild during pregnancy and Severe for lactating mothers. Further, the section on Moxitas 125 Syrup related warnings talks about Moxitas 125 Syrup's effects on the liver, heart and kidney.
Moxitas 125 Syrup is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Eczema are examples of such conditions. Other contraindications of Moxitas 125 Syrup have been discussed in the sections ahead.
Drug reaction of Moxitas 125 Syrup with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Moxitas 125 Syrup, it is important to know that it is safe while driving, and is habit-forming.
Moxitas 125 Syrup is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Moxitas 125 Syrup safe for pregnant women?
Moxitas has little to no side effects in pregnant women.
Is the use of Moxitas 125 Syrup safe during breastfeeding?
Taking Moxitas may lead to serious side effects if you are breastfeeding. Moxitas should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Moxitas 125 Syrup on the Kidneys?
Using Moxitas does not have any harmful effects on kidneys.
What is the effect of Moxitas 125 Syrup on the Liver?
Moxitas has very mild side effects on the liver.
What is the effect of Moxitas 125 Syrup on the Heart?
Moxitas can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Moxitas 125 Syrup unless your doctor advises you to do so -
Is this Moxitas 125 Syrup habit forming or addictive?
No, you will not get addicted to Moxitas 125 Syrup.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Moxitas 125 Syrup as it does not make you drowsy.
Is it safe?
Moxitas 125 Syrup is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Moxitas 125 Syrup is not used to treat mental disorders.
Interaction between Food and Moxitas 125 Syrup
It is safe to take Moxitas 125 Syrup with food.
Interaction between Alcohol and Moxitas 125 Syrup
Drinking alcohol while taking Moxitas 125 Syrup may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amoxil (amoxicillin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 657, 658, 702, 712, 721, 722, 723, 762
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 148-150